RhinAdvil (ibuprofen 200 mg / pseudoephedrine-HCl 30 mg) tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RhinAdvil (ibuprofen 200 mg / pseudoephedrine-HCl 30 mg) tablets, covering 2018-09-27 to 2018-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects [Phase 1]